Description
CJC-1295 (No-DAC), also called Modified GRF (1-29), is a short-acting synthetic analog of growth hormone-releasing hormone without the drug affinity complex. In laboratory research it is used as a GHRH receptor agonist with a brief activity window.
Preclinical literature describes investigations into growth hormone release, GHRH receptor signaling, and pulsatile secretion patterns, carried out using cell-based assays and animal studies. Its rapid clearance suits short-interval, time-resolved designs.
Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.
Reviews
There are no reviews yet.